| Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 years R Haupt, M Minkov, I Astigarraga, E Schäfer, V Nanduri, R Jubran, ... Pediatric blood & cancer 60 (2), 175-184, 2013 | 763 | 2013 |
| Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study E Bergsten, AC Horne, M Aricó, I Astigarraga, RM Egeler, AH Filipovich, ... Blood, The Journal of the American Society of Hematology 130 (25), 2728-2738, 2017 | 570 | 2017 |
| Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis H Gadner, M Minkov, N Grois, U Pötschger, E Thiem, M Arico, ... Blood, The Journal of the American Society of Hematology 121 (25), 5006-5014, 2013 | 477 | 2013 |
| Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel E Angelucci, S Matthes-Martin, D Baronciani, F Bernaudin, S Bonanomi, ... haematologica 99 (5), 811, 2014 | 405 | 2014 |
| A syndrome with congenital neutropenia and mutations in G6PC3 K Boztug, G Appaswamy, A Ashikov, AA Schäffer, U Salzer, J Diestelhorst, ... New England Journal of Medicine 360 (1), 32-43, 2009 | 394 | 2009 |
| Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification H Gadner, N Grois, U Pötschger, M Minkov, M Aricò, J Braier, V Broadbent, ... Blood, The Journal of the American Society of Hematology 111 (5), 2556-2562, 2008 | 387 | 2008 |
| Risk factors for diabetes insipidus in langerhans cell histiocytosis N Grois, U Pötschger, H Prosch, M Minkov, M Arico, J Braier, JI Henter, ... Pediatric blood & cancer 46 (2), 228-233, 2006 | 387 | 2006 |
| Treatment of E pstein B arr virus‐induced haemophagocytic lymphohistiocytosis with rituximab‐containing chemo‐immunotherapeutic regimens DB Chellapandian, R Das, K Zelley, SJ Wiener, H Zhao, DT Teachey, ... British journal of haematology 162 (3), 376-382, 2013 | 278 | 2013 |
| Pattern and course of single‐system disease in Langerhans cell histiocytosis data from the DAL‐HX 83‐and 90‐study C Titgemeyer, N Grois, M Minkov, B Flucher‐Wolfram, I Gatterer‐Menz, ... Medical and Pediatric Oncology: The Official Journal of SIOP—International …, 2001 | 241 | 2001 |
| A consensus review on malignancy‐associated hemophagocytic lymphohistiocytosis in adults N Daver, K McClain, CE Allen, SA Parikh, Z Otrock, C Rojas‐Hernandez, ... Cancer 123 (17), 3229-3240, 2017 | 207 | 2017 |
| Langerhans cell histiocytosis in children: history, classification, pathobiology, clinical manifestations, and prognosis J Krooks, M Minkov, AG Weatherall Journal of the American Academy of Dermatology 78 (6), 1035-1044, 2018 | 206 | 2018 |
| Multisystem Langerhans cell histiocytosis in children: current treatment and future directions M Minkov Pediatric Drugs 13, 75-86, 2011 | 206 | 2011 |
| Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies K Lehmberg, KE Nichols, JI Henter, M Girschikofsky, T Greenwood, ... Haematologica 100 (8), 997, 2015 | 194 | 2015 |
| Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator M Minkov, N Grois, A Heitger, U Pötschger, T Westermeier, H Gadner, ... Medical and pediatric oncology 39 (6), 581-585, 2002 | 182 | 2002 |
| Vemurafenib for refractory multisystem Langerhans cell histiocytosis in children: an international observational study J Donadieu, IA Larabi, M Tardieu, J Visser, C Hutter, E Sieni, N Kabbara, ... Journal of Clinical Oncology 37 (31), 2857-2865, 2019 | 179 | 2019 |
| Langerhans cell histiocytosis in neonates M Minkov, H Prosch, M Steiner, N Grois, U Pötschger, P Kaatsch, ... Pediatric blood & cancer 45 (6), 802-807, 2005 | 175 | 2005 |
| Malignancy‐associated haemophagocytic lymphohistiocytosis in children and adolescents K Lehmberg, B Sprekels, KE Nichols, W Woessmann, I Müller, M Suttorp, ... British journal of haematology 170 (4), 539-549, 2015 | 169 | 2015 |
| Leucocyte transfusions from rhG‐CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients C Peters, M Minkov, S Matthes‐Martin, U Pötschger, V Witt, G Mann, ... British journal of haematology 106 (3), 689-696, 1999 | 168 | 1999 |
| Genetic basis of congenital erythrocytosis: mutation update and online databases C Bento, MJ Percy, B Gardie, TM Maia, R van Wijk, S Perrotta, ... Human mutation 35 (1), 15-26, 2014 | 159 | 2014 |
| Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies M Minkov, N Grois, A Heitger, U Pötschger, T Westermeier, H Gadner Klinische Pädiatrie 212 (04), 139-144, 2000 | 154 | 2000 |
UPötschgerStatistikVerified email at ccri.at
